2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

BACKGROUND: The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to update the guideline published in 2020. METHODS: The panelists searched MEDLIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertoluci, Marcello Casaccia, Silva Júnior, Wellington S., Valente, Fernando, Araujo, Levimar Rocha, Lyra, Ruy, de Castro, João Jácome, Raposo, João Filipe, Miranda, Paulo Augusto Carvalho, Boguszewski, Cesar Luiz, Hohl, Alexandre, Duarte, Rui, Salles, João Eduardo Nunes, Silva-Nunes, José, Dores, Jorge, Melo, Miguel, de Sá, João Roberto, Neves, João Sérgio, Moreira, Rodrigo Oliveira, Malachias, Marcus Vinícius Bolívar, Lamounier, Rodrigo Nunes, Malerbi, Domingos Augusto, Calliari, Luis Eduardo, Cardoso, Luis Miguel, Carvalho, Maria Raquel, Ferreira, Hélder José, Nortadas, Rita, Trujilho, Fábio Rogério, Leitão, Cristiane Bauermann, Simões, José Augusto Rodrigues, dos Reis, Mónica Isabel Natal, Melo, Pedro, Marcelino, Mafalda, Carvalho, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354939/
https://www.ncbi.nlm.nih.gov/pubmed/37468901
http://dx.doi.org/10.1186/s13098-023-01121-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354939/
https://www.ncbi.nlm.nih.gov/pubmed/37468901
http://dx.doi.org/10.1186/s13098-023-01121-x

Ejemplares similares